Skip Ribbon Commands
Skip to main content



LifePearl™ microspheres have specific features that offer value in DEM-TACE procedures including a tight calibration and size distribution, a long time in suspension or the highest doxorubicin elution profile of all drug-eluting microspheres1 and a broad range of treatment options.

Veloso et al2 reported results from one of the largest multicentric cohorts of unresectable HCC patients (n=580) treated with
LifePearl™ microspheres to date:
  • Over 4 years Median OS (50.8 months [95% CI 44.7–NE])
  • 60.1% complete response rate exceeding what is reported in previous studies.3,4,5

​The Holmium Platform delivers a first in SIRT: a comprehensive end-to-end platform for treating unresectable liver tumours.
The Holmium Platform consists of three integrated products that allow you to select patients with confidence, deliver treatment with precision, and plan and verify with accuracy.
The Holmium Platform: delivering Individualized Treatment to the right Patient.​

​​TATO (Thermal Ablation Treatments for Oncology) is a 2.450 Mhz Microwave Thermal Ablation System that allows you to enhance the visibility and control on your ablation procedures, using up to 4 antennas simultaneously. Individualize the HCC treatment in open surgery, percutaneous or laparoscopic approach by choosing among 11G, 14G, 17G, and 18G antennas in various lengths. Choose a combination of a number of antennas, gauge, time, and power applied, to achieve from very small to very large ablation areas. The low presence of artifacts and gas bubbles allows to see vital structures and ablation progression under ultrasound guidance6, to approach challenging locations with confidence.

Progreat™ Microcatheter System, Progreat Lambda™ Microcatheter System and Radifocus Guidewire GT with Gold coil Guidewire are Terumo legacy​ solutions for a precise and selective access to target lesions, designed for uncompromised navigability7 and controlled therapeutic embolization.

Occlusafe™ Temporary Occlusion Microcatheter is a balloon-microcatheter which allows a local flow redistribution, resulting in an high-density accumulation of the therapeutics into the target lesion8 and in a reduced non-target  embolization.9

1 De Baere T et al. J Vasc Interv Radiol 2016;27:1425–31 
2 Veloso Gomes et al Cardiovasc Intervent Radiol 46, pages 436–446 (2023) 
3 Meyer T, et al. Lancet Gastroenterol Hepatol. 2017 
4 Kudo M, et al. Gut. 2020 
5 Lencioni R, et al. J Hepatology. 2016436–446 (2023) 
6 hep-2022-0002 - Eduardo Crespo liver ablation
7 Bench testing done by Terumo Corporation. Data on file (TC-Pro107). Bench test data may not necessarily be indicative of clinical performance
8 Irie Toshiyuki (2013): Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurementof balloon occlude arterial stump pressure. Cardiovasc Intervent Radiol. DOI: 10.1001/s00270-012-0476-z
9 Terumitsu Hasebe; Minimally Invasive Therapy & Allied Technologies. 2015 Apr;24(2):94-100. doi: 10.3109/13645706.2014.951657. Epub 2014 Sep 29. PubMed​


What the evidence says

Discover our clinical evidence and case studies concerning this topic.

Upcoming events

Mauris sed purus volutpat, convallis nibh ac, feugiat lorem. Sed dignissim arcu eulala.

16th edition of the Anecorm Congress in Malaga
September 27 - 29 , Spain
All events

Do you need more info about this product?

Our sales representatives are here for you.

Contact us
Send us a message
I have read and accept Terumo Privacy And Cookies Policy and the Terms Of Use*
I wish to receive information and marketing updates from Terumo.
* mandatory fields

Thank you for contacting us!

We typically respond within 2 business days and will come back to you as soon as possible.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public

For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.